DrAhmad Zuhier Mohammad Bahlool

Dr. Bahlool is a pharmacist and a lecturer in Pharmacy at the School of Pharmacy and Biomolecular Sciences at Royal College of Surgeons in Ireland (RCSI), and the International College for Pharmaceutical Innovation (ICPI) , SUDA, Suzhou, China. He previously worked as a Process Development Scientist at CureVac SE in Tübingen, Germany, contributing to the development and scale-up of GMP- compliant mRNA-LNP vaccine formulations. He served as Assistant Professor of pharmaceutical sciences at the school of pharmacy at Al-Zaytoonah University of Jordan (ZUJ). 

Dr. Bahlool obtained his BSc of Pharmacy from the University of Jordan. He then completed a joint Master’s degree in Nanomedicine for Drug Delivery through Erasmus Mundus joint Master’s program Jointly between four universities Université Paris Cité and the University of Angers in France, the University of Pavia in Italy, and the University of Patras in Greece. He was then awarded his PhD in Pharmaceutical Sciences from the Royal College of Surgeons in Ireland (RCSI). His doctoral research focused on the development of inhalable nanoparticle-based host-directed immunotherapies for tuberculosis. Dr. Bahlool research interest is in translational pharmaceutics, biopharmaceutics, nanomedicine, bio-nanointeraction, drug targeting, Inhalable and pulmonary therapeutics, RNA-based therapeutics, mRNA vaccine technologies and long acting injectables development.